Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation
The primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with a…
Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more
Estimated
~$10 – $8,750
Alexion Pharmaceuticals, Inc.NCT06744647
Assessment of Changes in Normal and Pathological Immune Factors in Patients Undergoing Plasma Exchange
Patients who have immune mediated diseases commonly undergo plasma exchange (PLEX) procedures to remove pathological substances, typically believed to be antib…
Antibody-mediated RejectionNMO Spectrum DisorderTTP+1 more
Estimated
~$10 – $1,125
Charles M KnudsonNCT05004493